Wordt geladen...
Preclinical Testing of CAR T Cells in a Patient-Derived Xenograft Model of Glioblastoma
Glioblastoma (GBM) is the most common malignant adult brain tumor that is resistant to the standard care therapy. Advances in chimeric antigen receptor (CAR) T cell therapies have spurred renewed interest in developing CAR T cell therapies to target chemoradiotherapy-resistant brain tumor-initiating...
Bewaard in:
| Gepubliceerd in: | STAR Protoc |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Elsevier
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7757398/ https://ncbi.nlm.nih.gov/pubmed/33377068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xpro.2020.100174 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|